Technetium Tc 99m Exametazime
"Technetium Tc 99m Exametazime" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A gamma-emitting RADIONUCLIDE IMAGING agent used in the evaluation of regional cerebral blood flow and in non-invasive dynamic biodistribution studies and MYOCARDIAL PERFUSION IMAGING. It has also been used to label leukocytes in the investigation of INFLAMMATORY BOWEL DISEASES.
| Descriptor ID |
D019690
|
| MeSH Number(s) |
D02.092.570.665.810 D02.691.825.562
|
| Concept/Terms |
Technetium Tc 99m Exametazime- Technetium Tc 99m Exametazime
- Tc-99m-Exametazime
- Tc 99m Exametazime
- 99m-Tc-HMPAO
- 99mTc-HMPAO
- Technetium Tc 99m Hexamethylpropylene-amine Oxime
- Technetium Tc 99m Hexamethylpropylene amine Oxime
- Tc-99m-Hexamethylpropyleneamine Oxime
- Tc 99m Hexamethylpropyleneamine Oxime
- Technetium Tc 99m Hexamethylpropyleneamine Oxime
- Tc-99m HMPAO
|
Below are MeSH descriptors whose meaning is more general than "Technetium Tc 99m Exametazime".
Below are MeSH descriptors whose meaning is more specific than "Technetium Tc 99m Exametazime".
This graph shows the total number of publications written about "Technetium Tc 99m Exametazime" by people in this website by year, and whether "Technetium Tc 99m Exametazime" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 3 | 3 |
| 1996 | 0 | 2 | 2 |
| 1997 | 0 | 4 | 4 |
| 1998 | 0 | 2 | 2 |
| 1999 | 0 | 1 | 1 |
| 2000 | 2 | 2 | 4 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 0 | 1 | 1 |
| 2005 | 1 | 1 | 2 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 2 | 3 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2024 | 1 | 0 | 1 |
Below are the most recent publications written about "Technetium Tc 99m Exametazime" by people in Profiles.
-
A multi-site 99mTc-HMPAO SPECT study of cerebral blood flow in a community sample of patients with major depression. Transl Psychiatry. 2024 Jun 03; 14(1):234.
-
Ultrasound-guided injection of the cranial tibial artery for stem cell administration in horses. Equine Vet J. 2019 Sep; 51(5):681-687.
-
Scintigraphic Tracking of Allogeneic Mesenchymal Stem Cells in the Distal Limb After Intra-Arterial Injection in Standing Horses. Vet Surg. 2016 Jul; 45(5):619-24.
-
Scintigraphic tracking of mesenchymal stem cells after portal, systemic intravenous and splenic administration in healthy beagle dogs. Vet Radiol Ultrasound. 2015 May-Jun; 56(3):327-34.
-
Scintigraphic tracking of mesenchymal stem cells after intravenous regional limb perfusion and subcutaneous administration in the standing horse. Vet Surg. 2015 Apr; 44(3):273-80.
-
Monitoring the efficacy of dendritic cell vaccination by early detection of (99m) Tc-HMPAO-labelled CD4(+) T cells. Eur J Immunol. 2014 Jul; 44(7):2188-91.
-
Scintigraphic comparison of intra-arterial injection and distal intravenous regional limb perfusion for administration of mesenchymal stem cells to the equine foot. Equine Vet J. 2014 Jul; 46(4):479-83.
-
Distribution and persistence of technetium-99 hexamethyl propylene amine oxime-labelled bone marrow-derived mesenchymal stem cells in experimentally induced tendon lesions after intratendinous injection and regional perfusion of the equine distal limb. Equine Vet J. 2013 Nov; 45(6):726-31.
-
Vascular physiology and protein disposition in a preclinical model of neurodegeneration. Mol Pharm. 2013 May 06; 10(5):1514-21.
-
Brain uptake of Tc99m-HMPAO correlates with clinical response to the novel redox modulating agent EPI-743 in patients with mitochondrial disease. Mol Genet Metab. 2012 Dec; 107(4):690-9.